Amanote Research

Amanote Research

    RegisterSign In

Safety of Antiretroviral Drugs

Arhiv za Farmaciju - Serbia
doi 10.5937/arhfarm1604161a
Full Text
Open PDF
Abstract

Available in full text

Categories
PharmacologyPharmaceutical Science
Date

January 1, 2016

Authors
Milena AnđelkovićAleksandra BuhaPredrag VukomanovićVesna Matović
Publisher

Centre for Evaluation in Education and Science (CEON/CEES)


Related search

Hypersensitivity to Antiretroviral Drugs

European Annals of Allergy and Clinical Immunology
AllergyImmunology
2018English

Safety of Drugs.

BMJ
1968English

Impact of Antiretroviral Drugs on the Microbiome

Current Opinion in HIV and AIDS
VirologyOncologyInfectious DiseasesImmunologyHematology
2018English

HIV Patients Need New Antiretroviral Drugs

British Medical Journal
Medicine
2005English

Evidence-Based TDM for Antiretroviral Drugs

Retrovirology
VirologyInfectious Diseases
2010English

Systematic Review of the Efficacy and Safety of Antiretroviral Drugs Against SARS, MERS, or COVID-19: Initial Assessment

Journal of the International AIDS Society
EnvironmentalPublic HealthInfectious DiseasesOccupational Health
2020English

Molecular Mechanism of Potent Capsid-Targeting Antiretroviral Drugs

Biophysical Journal
Biophysics
2019English

Inhibition of Human Endogenous Retrovirus-K by Antiretroviral Drugs

Retrovirology
VirologyInfectious Diseases
2017English

Neuropsychiatric Effects of Tenofovir in Comparison With Other Antiretroviral Drugs

Neurobehavioral HIV Medicine
DermatologyPsychiatryMental HealthInfectious DiseasesBehavioral Neuroscience
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy